Innovator Ibd 50 Etf Market Value
| FFTY Etf | USD 29.17 0.67 2.25% |
| Symbol | Innovator |
The market value of Innovator IBD 50 is measured differently than its book value, which is the value of Innovator that is recorded on the company's balance sheet. Investors also form their own opinion of Innovator IBD's value that differs from its market value or its book value, called intrinsic value, which is Innovator IBD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovator IBD's market value can be influenced by many factors that don't directly affect Innovator IBD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovator IBD's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innovator IBD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovator IBD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Innovator IBD 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Innovator IBD's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Innovator IBD.
| 11/22/2024 |
| 12/22/2024 |
If you would invest 0.00 in Innovator IBD on November 22, 2024 and sell it all today you would earn a total of 0.00 from holding Innovator IBD 50 or generate 0.0% return on investment in Innovator IBD over 30 days. Innovator IBD is related to or competes with Invesco NASDAQ, WisdomTree Cloud, Global X, and ARK Fintech. The fund will normally invest at least 80 percent of its net assets in securities that comprise the index More
Innovator IBD Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Innovator IBD's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Innovator IBD 50 upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.78 | |||
| Information Ratio | 0.0752 | |||
| Maximum Drawdown | 11.25 | |||
| Value At Risk | (2.05) | |||
| Potential Upside | 3.15 |
Innovator IBD Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Innovator IBD's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Innovator IBD's standard deviation. In reality, there are many statistical measures that can use Innovator IBD historical prices to predict the future Innovator IBD's volatility.| Risk Adjusted Performance | 0.0794 | |||
| Jensen Alpha | 0.1472 | |||
| Total Risk Alpha | 0.1065 | |||
| Sortino Ratio | 0.0756 | |||
| Treynor Ratio | 0.3742 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Innovator IBD's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Innovator IBD 50 Backtested Returns
At this stage we consider Innovator Etf to be very steady. Innovator IBD 50 holds Efficiency (Sharpe) Ratio of 0.0757, which attests that the entity had a 0.0757% return per unit of risk over the last 3 months. We have found thirty technical indicators for Innovator IBD 50, which you can use to evaluate the volatility of the entity. Please check out Innovator IBD's Downside Deviation of 1.78, risk adjusted performance of 0.0794, and Market Risk Adjusted Performance of 0.3842 to validate if the risk estimate we provide is consistent with the expected return of 0.14%. The etf retains a Market Volatility (i.e., Beta) of 0.42, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Innovator IBD's returns are expected to increase less than the market. However, during the bear market, the loss of holding Innovator IBD is expected to be smaller as well.
Auto-correlation | -0.25 |
Weak reverse predictability
Innovator IBD 50 has weak reverse predictability. Overlapping area represents the amount of predictability between Innovator IBD time series from 22nd of November 2024 to 7th of December 2024 and 7th of December 2024 to 22nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Innovator IBD 50 price movement. The serial correlation of -0.25 indicates that over 25.0% of current Innovator IBD price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.25 | |
| Spearman Rank Test | -0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.55 |
Innovator IBD 50 lagged returns against current returns
Autocorrelation, which is Innovator IBD etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Innovator IBD's etf expected returns. We can calculate the autocorrelation of Innovator IBD returns to help us make a trade decision. For example, suppose you find that Innovator IBD has exhibited high autocorrelation historically, and you observe that the etf is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Innovator IBD regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Innovator IBD etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Innovator IBD etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Innovator IBD etf over time.
Current vs Lagged Prices |
| Timeline |
Innovator IBD Lagged Returns
When evaluating Innovator IBD's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Innovator IBD etf have on its future price. Innovator IBD autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Innovator IBD autocorrelation shows the relationship between Innovator IBD etf current value and its past values and can show if there is a momentum factor associated with investing in Innovator IBD 50.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Innovator IBD 50 offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innovator IBD's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innovator Ibd 50 Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Innovator Ibd 50 Etf:Check out Innovator IBD Correlation, Innovator IBD Volatility and Innovator IBD Alpha and Beta module to complement your research on Innovator IBD. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Innovator IBD technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.